Eugenol protects against citrinin-induced cytotoxicity and oxidative damages in cultured human colorectal HCT116 cells.


Journal

Environmental science and pollution research international
ISSN: 1614-7499
Titre abrégé: Environ Sci Pollut Res Int
Pays: Germany
ID NLM: 9441769

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 21 02 2019
accepted: 14 08 2019
pubmed: 2 9 2019
medline: 7 1 2020
entrez: 2 9 2019
Statut: ppublish

Résumé

This study aimed to investigate the protective effects of Eugenol (EUG), an effective antioxidant phenolic compound with a radical scavenging activity against citrinin (CTN)-induced toxicity in vitro using HCT116 cells. CTN is a well-known mycotoxin found in different constituents of the food chain. This environmental contaminant produces free radicals which interacts with cellular macromolecules and produces oxidation of protein, lipid, and DNA. The cytotoxic effects were monitored by measuring cell viability, reactive oxygen species (ROS) generation, antioxidant enzyme activities, malondialdehyde (MDA) production, protein oxidation, and DNA fragmentation. Our results have shown that the pretreatment of HCT116 cells with EUG, 2 h prior to citrinin (CTN) exposure, significantly decreased CTN-induced cell death, inhibited ROS generation, modulated activities of both catalase (CAT) and superoxide dismutase (SOD), and reduced MDA production. Level of protein-bound sulfhydryls and DNA fragmentation were also declined as compared with CTN-treated cells. These findings suggest that EUG would be an effective protective agent against CTN-induced oxidative stress, and thereby, it may complement and add to the functions of antioxidant vitamins and enzymes as a protection against the cytotoxicity of this mycotoxin.

Identifiants

pubmed: 31473926
doi: 10.1007/s11356-019-06212-9
pii: 10.1007/s11356-019-06212-9
doi:

Substances chimiques

Anti-Infective Agents 0
Antioxidants 0
Reactive Oxygen Species 0
Citrinin 3S697X6SNZ
Eugenol 3T8H1794QW
Malondialdehyde 4Y8F71G49Q
Catalase EC 1.11.1.6
Superoxide Dismutase EC 1.15.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

31374-31383

Références

Asian Pac J Cancer Prev. 2011;12(8):1989-93
pubmed: 22292639
J Biochem Mol Toxicol. 1998;12(5):291-7
pubmed: 9664235
Arch Biochem Biophys. 1959 May;82(1):70-7
pubmed: 13650640
Cancer Lett. 1983 Jan;17(3):281-7
pubmed: 6831385
Nutr J. 2010 Jan 22;9:3
pubmed: 20096093
Arch Pharm Res. 2011 May;34(5):821-8
pubmed: 21656368
Chem Res Toxicol. 1992 Mar-Apr;5(2):227-31
pubmed: 1322737
Indian J Med Sci. 2007 Jan;61(1):9-14
pubmed: 17197733
IARC Sci Publ. 1991;(115):83-7
pubmed: 1820357
Toxicol Lett. 2005 Jan 15;155(1):27-34
pubmed: 15585356
Toxicon. 2014 Jun;84:1-6
pubmed: 24680766
BMC Cancer. 2013 Dec 13;13:600
pubmed: 24330704
Clin Biochem. 1999 Aug;32(6):491-4
pubmed: 10667489
Anal Biochem. 1983 Oct 1;134(1):111-6
pubmed: 6660480
Int J Biochem Cell Biol. 2009 Mar;41(3):666-76
pubmed: 18718551
Arh Hig Rada Toksikol. 2009 Dec;60(4):457-64
pubmed: 20061247
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31(1):139-48
pubmed: 24199782
Methods Enzymol. 1994;233:357-63
pubmed: 8015470
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Toxicol Appl Pharmacol. 1991 Jul;109(3):455-63
pubmed: 1853344
J Radiat Res. 2004 Sep;45(3):435-40
pubmed: 15613789
J Biol Chem. 2007 Aug 17;282(33):24407-15
pubmed: 17576767
Anal Biochem. 1979 Jun;95(2):351-8
pubmed: 36810
Eur J Pharmacol. 2009 Nov 25;623(1-3):132-40
pubmed: 19769960
Toxicology. 2010 Feb 9;268(3):204-12
pubmed: 20036707
Hum Toxicol. 1985 Sep;4(5):491-501
pubmed: 2997022
Anal Biochem. 1968 Oct 24;25(1):192-205
pubmed: 4973948
Molecules. 2012 Jun 06;17(6):6953-81
pubmed: 22728369
Neurochem Res. 1994 Mar;19(3):283-8
pubmed: 8177367
Toxins (Basel). 2013 Sep 17;5(9):1574-86
pubmed: 24048364
Neurotoxicology. 2016 Mar;53:334-342
pubmed: 26584763
J Appl Toxicol. 2007 Jul-Aug;27(4):337-41
pubmed: 17265422
Toxicology. 2008 Sep 29;251(1-3):1-7
pubmed: 18638518
Toxicol Appl Pharmacol. 2003 Sep 15;191(3):255-63
pubmed: 13678658
Eur J Biochem. 1974 Sep 16;47(3):469-74
pubmed: 4215654
J Toxicol Environ Health A. 2017;80(23-24):1230-1241
pubmed: 29165056
Food Chem Toxicol. 1996 Jan;34(1):33-42
pubmed: 8603795
Methods Enzymol. 1984;105:121-6
pubmed: 6727660
Food Chem Toxicol. 2013 May;55:106-12
pubmed: 23313798
J Pharm Pharmacol. 2014 May;66(5):733-46
pubmed: 24372555

Auteurs

Amal Salah (A)

Laboratory of Research on Biologically Compatible Compounds, Faculty of Dental Medicine, Monastir University, rue Avicenne, 5019, Monastir, Tunisia.
Faculty of Sciences of Bizerte, Carthage University, Tunis, Tunisia.

Chayma Bouaziz (C)

Laboratory of Research on Biologically Compatible Compounds, Faculty of Dental Medicine, Monastir University, rue Avicenne, 5019, Monastir, Tunisia. c.chayma@ymail.com.

Ines Amara (I)

Laboratory of Research on Biologically Compatible Compounds, Faculty of Dental Medicine, Monastir University, rue Avicenne, 5019, Monastir, Tunisia.

Salwa Abid-Essefi (S)

Laboratory of Research on Biologically Compatible Compounds, Faculty of Dental Medicine, Monastir University, rue Avicenne, 5019, Monastir, Tunisia.

Hassen Bacha (H)

Laboratory of Research on Biologically Compatible Compounds, Faculty of Dental Medicine, Monastir University, rue Avicenne, 5019, Monastir, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH